SEARCH

SEARCH BY CITATION

References

  • Abdo H., Mahe M. M., Derkinderen P., Bach-Ngohou K., Neunlist M. and Lardeux B. (2012) The omega-6 derivative 15d-PGJ2 is involved in neuroprotection by enteric glial cells against oxidative stress. J. Physiol. 590, 27392750.
  • Barres B. A. (2008) The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60, 430440.
  • Bell K. F., Al-Mubarak B., Fowler J. H. et al. (2011) Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc. Natl Acad. Sci. USA 108, E1E2.
  • Carrier R. L., Ma T. C., Obrietan K. and Hoyt K. R. (2006) A sensitive and selective assay of neuronal degeneration in cell culture. J. Neurosci. Methods 154, 239244.
  • Cho H. Y., Gladwell W., Wang X., Chorley B., Bell D., Reddy S. P. and Kleeberger S. R. (2010) Nrf2-regulated PPAR{gamma} expression is critical to protection against acute lung injury in mice. Am. J. Respir. Crit. Care Med. 182, 170182.
  • Davies G. F., Khandelwal R. L., Wu L., Juurlink B. H. and Roesler W. J. (2001) Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism. Biochem. Pharmacol. 62, 10711079.
  • Diab A., Deng C., Smith J. D., Hussain R. Z., Phanavanh B., Lovett-Racke A. E., Drew P. D. and Racke M. K. (2002) Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 168, 25082515.
  • Dinkova-Kostova A. T., Holtzclaw W. D., Cole R. N., Itoh K., Wakabayashi N., Katoh Y., Yamamoto M. and Talalay P. (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl Acad. Sci. USA 99, 1190811913.
  • Doyle K. and Fitzpatrick F. A. (2010) Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. J. Biol. Chem. 285, 1741717424.
  • Dringen R., Gutterer J. M. and Hirrlinger J. (2000) Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 267, 49124916.
  • Feinstein D. L., Spagnolo A., Akar C., Weinberg G., Murphy P., Gavrilyuk V. and Dello Russo C. (2005) Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key? Biochem. Pharmacol. 70, 177188.
  • Forman B. M., Tontonoz P., Chen J., Brun R. P., Spiegelman B. M. and Evans R. M. (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83, 803812.
  • Garcia-Bueno B., Caso J. R., Perez-Nievas B. G., Lorenzo P. and Leza J. C. (2007) Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats. Neuropsychopharmacology 32, 12511260.
  • Genovese T., Esposito E., Mazzon E., Di Paola R., Muia C., Meli R., Bramanti P. and Cuzzocrea S. (2008) Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury. Shock 30, 142152.
  • Gilroy D. W., Colville-Nash P. R., Willis D., Chivers J., Paul-Clark M. J. and Willoughby D. A. (1999) Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5, 698701.
  • Giri S., Rattan R., Singh A. K. and Singh I. (2004) The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. J. Immunol. 173, 51965208.
  • Gohil K., Godzdanker R., O'Roark E., Schock B. C., Kaini R. R., Packer L., Cross C. E. and Traber M. G. (2004) Alpha-tocopherol transfer protein deficiency in mice causes multi-organ deregulation of gene networks and behavioral deficits with age. Ann. N. Y. Acad. Sci. 1031, 109126.
  • Haskew-Layton R. E., Payappilly J. B., Smirnova N. A. et al. (2010) Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway. Proc. Natl Acad. Sci. USA 107, 1738517390.
  • Haskew-Layton R. E., Ma T. C. and Ratan R. R. (2011) Reply to Bell et al.: Nrf2-dependent and -independent mechanisms of astrocytic neuroprotection. Proc. Natl Acad. Sci. USA 108, E3E4.
  • Hatanaka M., Shibata N., Shintani N., Haba R., Hayata A., Hashimoto H. and Baba A. (2010) 15d-prostaglandin J2 enhancement of nerve growth factor-induced neurite outgrowth is blocked by the chemoattractant receptor- homologous molecule expressed on T-helper type 2 cells (CRTH2) antagonist CAY10471 in PC12 cells. J. Pharmacol. Sci. 113, 8993.
  • Hong F., Sekhar K. R., Freeman M. L. and Liebler D. C. (2005) Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation. J. Biol. Chem. 280, 3176831775.
  • Kaileh M. and Sen R. (2010) Role of NF-kappaB in the anti-inflammatory effects of tocotrienols. J. Am. Coll. Nutr. 29, 334S339S.
  • Kansanen E., Kivela A. M. and Levonen A. L. (2009) Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta12,14-prostaglandin J2. Free Radic. Biol. Med. 47, 13101317.
  • Kapadia R., Yi J. H. and Vemuganti R. (2008) Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front. Biosci. 13, 18131826.
  • Kaspar J. W., Niture S. K. and Jaiswal A. K. (2009) Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic. Biol. Med. 47, 13041309.
  • Kerr B. J., Girolami E. I., Ghasemlou N., Jeong S. Y. and David S. (2008) The protective effects of 15-deoxy-delta-(12,14)-prostaglandin J2 in spinal cord injury. Glia 56, 436448.
  • Kiaei M. (2008) Peroxisome proliferator-activated receptor-gamma in amyotrophic lateral sclerosis and Huntington's disease. PPAR Res. 2008, 418765.
  • Kim J. B., Wright H. M., Wright M. and Spiegelman B. M. (1998) ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc. Natl Acad. Sci. USA 95, 43334337.
  • Kim J. W., Li M. H., Jang J. H., Na H. K., Song N. Y., Lee C., Johnson J. A. and Surh Y. J. (2008) 15-Deoxy-Delta(12,14)-prostaglandin J(2) rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2. Biochem. Pharmacol. 76, 15771589.
  • Kliewer S. A., Lenhard J. M., Willson T. M., Patel I., Morris D. C. and Lehmann J. M. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83, 813819.
  • Kobayashi M., Li L., Iwamoto N., Nakajima-Takagi Y., Kaneko H., Nakayama Y., Eguchi M., Wada Y., Kumagai Y. and Yamamoto M. (2009) The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol. Cell. Biol. 29, 493502.
  • Koharudin L. M., Liu H., Di Maio R., Kodali R. B., Graham S. H. and Gronenborn A. M. (2010) Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1. Proc. Natl Acad. Sci. USA 107, 68356840.
  • Kronke G., Kadl A., Ikonomu E. et al. (2007) Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler. Thromb. Vasc. Biol. 27, 12761282.
  • Lee M., Cho T., Jantaratnotai N., Wang Y. T., McGeer E. and McGeer P. L. (2010) Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J. 24, 25332545.
  • Li Y. and Jaiswal A. K. (1994) Human antioxidant-response-element-mediated regulation of type 1 NAD(P)H:quinone oxidoreductase gene expression. Effect of sulfhydryl modifying agents. Eur. J. Biochem. 226, 3139.
  • Moehlenkamp J. D. and Johnson J. A. (1999) Activation of antioxidant/electrophile-responsive elements in IMR-32 human neuroblastoma cells. Arch. Biochem. Biophys. 363, 98106.
  • Muller D. P. (2010) Vitamin E and neurological function. Mol. Nutr. Food Res. 54, 710718.
  • Oh J. Y., Giles N., Landar A. and Darley-Usmar V. (2008) Accumulation of 15-deoxy-delta(12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction. Biochem. J. 411, 297306.
  • Park E. J., Park S. Y., Joe E. H. and Jou I. (2003) 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia. J. Biol. Chem. 278, 1474714752.
  • Pereira M. P., Hurtado O., Cardenas A. et al. (2006) Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J. Cereb. Blood Flow Metab. 26, 218229.
  • Phulwani N. K., Feinstein D. L., Gavrilyuk V., Akar C. and Kielian T. (2006) 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway. J. Neurochem. 99, 13891402.
  • Prestera T., Talalay P., Alam J., Ahn Y. I., Lee P. J. and Choi A. M. (1995) Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements (ARE). Mol. Med. 1, 827837.
  • Rajakariar R., Hilliard M., Lawrence T., Trivedi S., Colville-Nash P., Bellingan G., Fitzgerald D., Yaqoob M. M. and Gilroy D. W. (2007) Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. Proc. Natl Acad. Sci. USA 104, 2097920984.
  • Renedo M., Gayarre J., Garcia-Dominguez C. A., Perez-Rodriguez A., Prieto A., Canada F. J., Rojas J. M. and Perez-Sala D. (2007) Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective. Biochemistry 46, 66076616.
  • Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M. and Santoro M. G. (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403, 103108.
  • Ryan S. D., Whitehead S. N., Swayne L. A. et al. (2009) Amyloid-beta42 signals tau hyperphosphorylation and compromises neuronal viability by disrupting alkylacylglycerophosphocholine metabolism. Proc. Natl Acad. Sci. USA 106, 2093620941.
  • Scher J. U. and Pillinger M. H. (2005) 15d-PGJ2: the anti-inflammatory prostaglandin? Clin. Immunol. 114, 100109.
  • Schoonjans K., Peinado-Onsurbe J., Lefebvre A. M., Heyman R. A., Briggs M., Deeb S., Staels B. and Auwerx J. (1996) PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 15, 53365348.
  • Sen C. K., Rink C. and Khanna S. (2010) Palm oil-derived natural vitamin E alpha-tocotrienol in brain health and disease. J. Am. Coll. Nutr. 29, 314S323S.
  • Shibata T., Yamada T., Ishii T., Kumazawa S., Nakamura H., Masutani H., Yodoi J. and Uchida K. (2003) Thioredoxin as a molecular target of cyclopentenone prostaglandins. J. Biol. Chem. 278, 2604626054.
  • Shih A. Y., Johnson D. A., Wong G., Kraft A. D., Jiang L., Erb H., Johnson J. A. and Murphy T. H. (2003) Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J. Neurosci. 23, 33943406.
  • Shih P. H., Hwang S. L., Yeh C. T. and Yen G. C. (2012) Synergistic effect of cyanidin and PPAR agonist against nonalcoholic steatohepatitis-mediated oxidative stress-induced cytotoxicity through MAPK and Nrf2 transduction pathways. J. Agric. Food Chem. 60, 29242933.
  • Sofroniew M. V. and Vinters H. V. (2010) Astrocytes: biology and pathology. Acta Neuropathol. 119, 735.
  • Surh Y. J., Na H. K., Park J. M., Lee H. N., Kim W., Yoon I. S. and Kim D. D. (2011) 15-Deoxy-Delta(1)(2), (1)(4)-prostaglandin J(2), an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling. Biochem. Pharmacol. 82, 13351351.
  • Syed M. A., Joo M., Abbas Z., Rodger D., Christman J. W., Mehta D. and Sadikot R. T. (2010) Expression of TREM-1 is inhibited by PGD2 and PGJ2 in macrophages. Exp. Cell Res. 316, 31403149.
  • Tjalkens R. B., Liu X., Mohl B., Wright T., Moreno J. A., Carbone D. L. and Safe S. (2008) The peroxisome proliferator-activated receptor-gamma agonist 1,1-bis(3'-indolyl)-1-(p-trifluoromethylphenyl)methane suppresses manganese-induced production of nitric oxide in astrocytes and inhibits apoptosis in cocultured PC12 cells. J. Neurosci. Res. 86, 618629.
  • Tontonoz P. and Spiegelman B. M. (2008) Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem. 77, 289312.
  • Toyomoto M., Ohta M., Okumura K., Yano H., Matsumoto K., Inoue S., Hayashi K. and Ikeda K. (2004) Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures. FEBS Lett. 562, 211215.
  • Vargas M. R. and Johnson J. A. (2009) The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev. Mol. Med. 11, e17.
  • Villacorta L., Zhang J., Garcia-Barrio M. T., Chen X. L., Freeman B. A., Chen Y. E. and Cui T. (2007) Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway. Am. J. Physiol. Heart Circ. Physiol. 293, H770H776.
  • Yamamoto T., Suzuki T., Kobayashi A., Wakabayashi J., Maher J., Motohashi H. and Yamamoto M. (2008) Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol. Cell. Biol. 28, 27582770.
  • Zhao X., Zhang Y., Strong R., Grotta J. C. and Aronowski J. (2006) 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. J. Cereb. Blood Flow Metab. 26, 811820.
  • Zhao X., Strong R., Zhang J., Sun G., Tsien J. Z., Cui Z., Grotta J. C. and Aronowski J. (2009) Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia. J. Neurosci. 29, 61866195.